Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/002390 stock hub

KRX/002390 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KRX/002390is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
129.3B
Korea Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
KRX/002390
In the news

Latest news · KRX/002390

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-0.8
P25 -17.1P50 0.7P75 8.5
ROIC0.5
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KRX/002390 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
216
Groups with data
11
Currency
KRW
Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
940
Enterprise value
KRW 481.5B
Exchange
Korea Stock Exchange
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
KR7002390003
Last refreshed
2026-05-10
Market cap
KRW 129.3B
Price
KRW 9,950
Price currency
KRW
Rev Per Employee
569,295,590.81x
Sector
Healthcare
Sic
2834
Symbol
krx/002390
Website
https://www.handok.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-1.67%
EV Earnings
-223.63x
EV/EBITDA
29.98x
EV/FCF
-48.74x
EV/Sales
0.9x
FCF yield
-7.64%
P/B ratio
0.46x
P/S ratio
0.24x
PE Ratio10 Y
69.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
0.62%
EBITDA Margin
5.01%
Gross margin
29.7%
Gross Profit
KRW 158.9B
Gross Profit Growth
0.96%
Gross Profit Growth Q
20.21%
Gross Profit Growth3 Y
-2.92%
Gross Profit Growth5 Y
-1.15%
Net Income
KRW -2.2B
Net Income Growth Quarters
3%
Net Income Growth Years
1%
Pretax Margin
-1.4%
Profit Margin
-0.4%
Profit Per Employee
KRW -2.3M
ROA
0.26
Roa5y
1.04
ROCE
0.88
ROE
-0.79
Roe5y
-4.38
ROIC
0.54
Roic5y
1.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr10y
-11.07%
Cagr15y
-0.09%
Cagr1y
-18.38%
Cagr20y
0.35%
Cagr3y
-11.73%
Cagr5y
-17.51%
Div CAGR10
7.18%
Div CAGR3
-20.63%
Div CAGR5
-7.79%
EPS Growth Quarters
3
EPS Growth Years
1
OCF Growth10 Y
-12.21%
OCF Growth3 Y
-49.28%
OCF Growth5 Y
-30.38%
Revenue Growth
5.48x
Revenue Growth Q
15.48x
Revenue Growth Quarters
3x
Revenue Growth Years
1x
Revenue Growth3 Y
-0.53x
Revenue Growth5 Y
1.22x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
KRW 0.68
Assets
KRW 790.8B
Cash
KRW 28.1B
Current Assets
KRW 319.7B
Current Liabilities
KRW 415.1B
Debt
KRW 378.6B
Debt EBITDA
KRW 14.13
Debt Equity
KRW 1.36
Debt FCF
KRW -38.32
Equity
KRW 278.3B
Interest Coverage
0.17
Liabilities
KRW 512.4B
Long Term Assets
KRW 471.1B
Long Term Liabilities
KRW 97.3B
Net Cash
KRW -350.5B
Net Cash By Market Cap
KRW -271
Net Debt EBITDA
KRW 13.08
Net Debt Equity
KRW 1.26
Tangible Book Value
KRW 194.3B
Tangible Book Value Per Share
KRW 16,404
WACC
4.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.77
Inventory Turnover
3.91
Net Working Capital
KRW 173.7B
Quick ratio
0.52
Working Capital
KRW -95.4B
Working Capital Turnover
KRW -9.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
3.44%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
KRW 200
Dividend Years
2
Dividend Yield
2.01%
Ex Div Date
2026-02-26
Last Dividend
KRW 200
Payout Frequency
Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-69.06%
1Y total return
-18.37%
200-day SMA
11,337.3
3Y total return
-31.22%
50-day SMA
10,532.6
50-day SMA vs 200-day SMA
50under200
5Y total return
-61.8%
All Time High
44,750
All Time High Change
-77.77%
All Time High Date
2020-08-05
All Time Low
909.8
All Time Low Change
993.66%
All Time Low Date
1992-01-20
ATR
263.6
Beta
0.34
Beta1y
0.14
Beta2y
0.19
Ch YTD
-11.16
High
10,030
High52
13,460
High52 Date
2025-07-30
High52ch
-26.08%
Low
9,900
Low52
9,900
Low52 Date
2026-05-08
Low52ch
0.51%
Ma50ch
-5.53%
Price vs 200-day SMA
-12.24%
RSI
36.56
RSI Monthly
31.89
RSI Weekly
33.28
Sharpe ratio
-0.63x
Sortino ratio
-0.62
Total Return
5.45%
Tr YTD
-9.62
Tr15y
-1.38%
Tr1m
-3.59%
Tr1w
-2.07%
Tr3m
-8.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
KRW 3.3B
Operating Income Growth3 Y
-51.3
Operating Income Growth5 Y
-35
Operating margin
0.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
7,011,081%
Net Borrowing
1,510,082,830
Shares Insiders
25.55%
Shares Institutions
0.59%
Shares Out
12,990,956
Shares Qo Q
-13.98%
Shares Yo Y
-3.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

62
MetricValue
Adjusted FCF
KRW -10.2B
Average Volume
32,727.5x
Bv Per Share
23,355.8
CAPEX
KRW -13.9B
Ch10y
-73.25
Ch15y
-20.72
Ch1m
-3.59
Ch1w
-2.07
Ch1y
-19.76
Ch20y
-25.19
Ch3m
-9.95
Ch3y
-34.97
Ch5y
-65.27
Ch6m
-12.87
Change
0.2%
Change From Open
0.2
Close
9,930
Days Gap
0
Depreciation Amortization
23,509,220,000
Dollar Volume
147,399,300
Earnings Date
2026-05-13
EBIT
KRW 3.3B
EBITDA
KRW 26.8B
EPS
KRW -162
F Score
5
FCF
KRW -9.9B
FCF EV Yield
-2.05x
FCF Per Share
KRW -760
Financing CF
-9,735,375,360
Fiscal Year End
December
Founded
1,954
Goodwill
44,503,067,000
Income Tax
KRW -5.3B
Investing CF
-22,369,669,240
Is Primary Listing
1
Last Earnings Date
2026-02-06
Last Report Date
2025-12-31
Last Split Date
2003-05-02
Last Split Type
Forward
Ma150
11,150.8
Ma150ch
-10.77%
Ma20
10,354
Ma20ch
-3.9%
Net CF
-27,976,188,220
Next Earnings Date
2026-05-13
Open
9,930
P OCF Ratio
32.46
Payment Date
2026-04-24
Position In Range
38.46
Ppne
213,547,540,640
Price Date
2026-05-08
Price EBITDA
KRW 4.82
Ptbv Ratio
0.67
Relative Volume
0.45x
Revenue
535,137,855,360x
SBC By Revenue
0.07x
Share Based Comp
354,475,000
Tax By Revenue
-0.99x
Tr20y
7.15%
Tr6m
-11.36%
Volume
14,814
Z Score
1.13
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

KRX/002390 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+2.0%
$200 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-7.8%
0 consecutive years of growth
Total shareholder yield
+5.4%
Next ex-dividend date: 2026-02-26
Performance

KRX/002390 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-18.4%
S&P 500 1Y: n/a
3Y total return
-31.2%
S&P 500 3Y: n/a
5Y total return
-61.8%
S&P 500 5Y: n/a
10Y total return
-69.1%
S&P 500 10Y: n/a
Ownership

Who owns KRX/002390?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.6%
Share of float held by funds and institutions
Insider ownership
+25.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-3.4%
Negative means the company is buying back shares.
Technical

KRX/002390 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.6
Neutral momentum band
Price vs 200-day MA
-12.2%
50/200-day relationship not available
Beta (5Y)
0.34
Less volatile than the market
Sharpe ratio
-0.63
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KRX/002390

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/002390 stock rating?

krx/002390 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/002390 analysis?

The full report lives at /stocks/krx/002390/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/002390?

The latest report frames krx/002390 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/002390 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

krx/002390 stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام